ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 811,91
1,49%
DAX
18 518,03
-0,44%
Brent Oil
83,39
-1,13%
Bitcoin
64 361,10
-0,76%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
08/07/201519h47Business WireTeva First to Receive Approval and Launch Generic Axert® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
06/07/201519h06Dow Jones NewsTeva May Raise Offer for Mylan to Range of $86 to $88 a Share -BloombergNYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/201514h39Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/201514h30Business WireTeva Launches Generic Aggrenox® Capsules in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
01/07/201514h00Business WireTeva and Xenon Provide Update on TV-45070 Phase 2b Study in Osteoarthritis PainNYSE:TEVATeva Pharmaceutical Industries Ltd
28/06/201517h03The Motley FoolThe Biotech Drug Lord: How One Man Is Conquering The Biotech SpaceNYSE:TEVATeva Pharmaceutical Industries Ltd
25/06/201514h00Business WireTeva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO TrialNYSE:TEVATeva Pharmaceutical Industries Ltd
24/06/201514h00Business WireTeva Launches PainMatters.com to Support Responsible Pain ManagementNYSE:TEVATeva Pharmaceutical Industries Ltd
19/06/201515h30Dow Jones NewsTeva Takes 4.6% Stake in MylanNYSE:TEVATeva Pharmaceutical Industries Ltd
19/06/201514h30Business WireTeva Completes the Purchase of 4.61 Percent Interest in Mylan N.V.NYSE:TEVATeva Pharmaceutical Industries Ltd
19/06/201503h42Dow Jones NewsTeva's Copaxone Patent Again Struck Down by U.S. Court -- 2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
19/06/201500h40Dow Jones NewsADRs End Higher; Telecom Italia RisesNYSE:TEVATeva Pharmaceutical Industries Ltd
18/06/201521h50Dow Jones NewsTeva's Copaxone Patent Loses AgainNYSE:TEVATeva Pharmaceutical Industries Ltd
18/06/201521h18Dow Jones NewsTeva's Copaxone Patent Again Struck Down by U.S. Court -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
18/06/201519h40Dow Jones NewsU.S. Court Again Strikes Down Teva's Copaxone PatentNYSE:TEVATeva Pharmaceutical Industries Ltd
18/06/201514h30Business WireTeva to Present New Findings at the American Headache Society (AHS) Meeting – Analysis of Migraine Phase IIb Studies Provid...NYSE:TEVATeva Pharmaceutical Industries Ltd
18/06/201514h00Business WireTeva and Microchips Biotech Announce Partnership to Enhance Patient Outcomes through Digital Drug Delivery TechnologyNYSE:TEVATeva Pharmaceutical Industries Ltd
16/06/201514h59Dow Jones NewsTeva: Trial for Movement Disorder Shows Promising ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd.
16/06/201514h00Business WireTeva Advances Pipeline of Movement Disorder Assets with Announcement of Positive Top-Line Data from the First Pivotal Study o...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/06/201514h00Business WireTeva Announces FDA Acceptance of the Biologics License Application for ReslizumabNYSE:TEVATeva Pharmaceutical Industries Ltd
10/06/201506h37Dow Jones NewsJudge Recommends Barring Law Firm From Advising on Teva-Mylan Takeover FightNYSE:TEVATeva Pharmaceutical Industries Ltd.
10/06/201503h50Dow Jones NewsJudge Recommends Barring Law Firm From Teva-Mylan Takeover FightNYSE:TEVATeva Pharmaceutical Industries Ltd
09/06/201522h00Business WireTeva to Present at the Goldman Sachs 36th Annual Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
06/06/201516h09The Motley Fool3 Surprising Biotech Stocks That Are Surging HigherNYSE:TEVATeva Pharmaceutical Industries Ltd
02/06/201516h00Business WireTeva Enhances ADHD Product Line with Generic INTUNIV® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
01/06/201519h03Edgar (US Regulatory)Specialized Disclosure Report (sd)NYSE:TEVATeva Pharmaceutical Industries Ltd
01/06/201514h30Business WireTeva Announces Exclusive Launch of Generic Actonel® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
29/05/201514h30Business WireTeva Enhances Extensive Women’s Health Portfolio with Launch of Generic Lomedia® 24 Fe TabletsNYSE:TEVATeva Pharmaceutical Industries Ltd
28/05/201519h19Dow Jones NewsTeva, FTC Reach $1.2 Billion Settlement on Cephalon's Provigil -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd.
28/05/201516h18Dow Jones NewsTeva, FTC Reach $1.2 Billion Settlement on Cephalon's ProvigilNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NASDAQ
HLSS
BIT
P1VD36
NLBNPIT1VD36 20991231 15...
BIT
UB8VR4
Unicredit Bank
BIT
P224S3
NLBNPIT224S3 20991231 16...
BIT
P1NIU5
BNP Paribas Issuance
LSE
CBU3
Ishr $ Gov 1-3a
BIT
BC
Brunello Cucinelli
LSE
UC04
Ubsetf Usagby
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés